- Home
- AIG vs HLN Comparison
AIG vs HLN Comparison
Compare AIG & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIG
- HLN
- Stock Information
- Founded
- AIG 1919
- HLN 2022
- Country
- AIG United States
- HLN United Kingdom
- Employees
- AIG N/A
- HLN N/A
- Industry
- AIG Life Insurance
- HLN Package Goods/Cosmetics
- Sector
- AIG Finance
- HLN Consumer Discretionary
- Exchange
- AIG Nasdaq
- HLN Nasdaq
- Market Cap
- AIG 49.2B
- HLN 48.2B
- IPO Year
- AIG N/A
- HLN N/A
- Fundamental
- Price
- AIG $79.49
- HLN $9.74
- Analyst Decision
- AIG Buy
- HLN Buy
- Analyst Count
- AIG 14
- HLN 1
- Target Price
- AIG $87.64
- HLN $10.95
- AVG Volume (30 Days)
- AIG 4.2M
- HLN 12.6M
- Earning Date
- AIG 08-06-2025
- HLN 08-04-2025
- Dividend Yield
- AIG 2.26%
- HLN 1.82%
- EPS Growth
- AIG N/A
- HLN 38.94
- EPS
- AIG N/A
- HLN 0.20
- Revenue
- AIG $26,858,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- AIG $3.19
- HLN $3.63
- Revenue Next Year
- AIG $3.44
- HLN $4.37
- P/E Ratio
- AIG N/A
- HLN $23.86
- Revenue Growth
- AIG N/A
- HLN N/A
- 52 Week Low
- AIG $69.00
- HLN $8.80
- 52 Week High
- AIG $88.07
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- AIG 33.48
- HLN 33.23
- Support Level
- AIG $79.61
- HLN $9.50
- Resistance Level
- AIG $81.94
- HLN $9.71
- Average True Range (ATR)
- AIG 1.20
- HLN 0.11
- MACD
- AIG -0.26
- HLN -0.02
- Stochastic Oscillator
- AIG 26.88
- HLN 30.38
About AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.